Detalles de la búsqueda
1.
Early Tumor Marker Response Predicts Treatment Outcomes in Patients with Unresectable Hepatocellular Carcinoma Receiving Combined Lenvatinib, Immune Checkpoint Inhibitors, and Transcatheter Arterial Chemoembolization Therapy.
J Hepatocell Carcinoma
; 10: 1827-1837, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37850079
Resultados
1 -
1
de 1
1
Próxima >
>>